PubRank

Jameel Iqbal

Author PubWeight™ 50.65‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 FSH directly regulates bone mass. Cell 2006 4.64
2 TSH is a negative regulator of skeletal remodeling. Cell 2003 4.34
3 Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest 2003 1.63
4 Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci U S A 2010 1.60
5 Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc Natl Acad Sci U S A 2008 1.46
6 Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A 2009 1.44
7 ACTH protects against glucocorticoid-induced osteonecrosis of bone. Proc Natl Acad Sci U S A 2010 1.26
8 Calcineurin regulates bone formation by the osteoblast. Proc Natl Acad Sci U S A 2005 1.16
9 Physiological loading of joints prevents cartilage degradation through CITED2. FASEB J 2010 1.12
10 Bone marrow oxytocin mediates the anabolic action of estrogen on the skeleton. J Biol Chem 2012 1.05
11 Disordered osteoclast formation and function in a CD38 (ADP-ribosyl cyclase)-deficient mouse establishes an essential role for CD38 in bone resorption. FASEB J 2003 1.03
12 Gaucher disease gene GBA functions in immune regulation. Proc Natl Acad Sci U S A 2012 1.02
13 TNF-induced gene expression oscillates in time. Biochem Biophys Res Commun 2008 1.01
14 Functional grouping of osteoclast genes revealed through microarray analysis. Biochem Biophys Res Commun 2007 1.00
15 Oxytocin deficiency impairs maternal skeletal remodeling. Biochem Biophys Res Commun 2009 1.00
16 Thyroid-stimulating hormone, thyroid hormones, and bone loss. Curr Osteoporos Rep 2009 1.00
17 Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts. Biochem Biophys Res Commun 2011 0.99
18 Minireview: The link between fat and bone: does mass beget mass? Endocrinology 2012 0.95
19 Proresorptive actions of FSH and bone loss. Ann N Y Acad Sci 2007 0.92
20 Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts. Am J Physiol Renal Physiol 2006 0.92
21 Bone loss or lost bone: rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss. Curr Osteoporos Rep 2009 0.91
22 HIV and bone loss. Curr Osteoporos Rep 2010 0.90
23 Bone loss in thyroid disease: role of low TSH and high thyroid hormone. Ann N Y Acad Sci 2007 0.89
24 A novel mechanism for coupling cellular intermediary metabolism to cytosolic Ca2+ signaling via CD38/ADP-ribosyl cyclase, a putative intracellular NAD+ sensor. FASEB J 2002 0.89
25 Ca(2+) influx through the osteoclastic plasma membrane ryanodine receptor. Am J Physiol Renal Physiol 2002 0.88
26 The role of FSH and TSH in bone loss and its clinical relevance. Curr Osteoporos Rep 2010 0.86
27 Translational medicine: Double protection for weakened bones. Nature 2012 0.86
28 TNF-induced oscillations in combinatorial transcription factor binding. Biochem Biophys Res Commun 2008 0.85
29 Vitamin C prevents hypogonadal bone loss. PLoS One 2012 0.85
30 Bone loss in anorexia nervosa: leptin, serotonin, and the sympathetic nervous system. Ann N Y Acad Sci 2010 0.83
31 Regulation of FSH receptor promoter activation in the osteoclast. Biochem Biophys Res Commun 2007 0.82
32 Disease-drug pairs revealed by computational genomic connectivity mapping on GBA1 deficient, Gaucher disease mice. Biochem Biophys Res Commun 2012 0.81
33 Cellular and molecular consequences of calcineurin A alpha gene deletion. Ann N Y Acad Sci 2007 0.81
34 Structure and functional regulation of the CD38 promoter. Biochem Biophys Res Commun 2006 0.81
35 Further evidence that FSH causes bone loss independently of low estrogen. Endocrine 2012 0.80
36 Further evidence for direct pro-resorptive actions of FSH. Biochem Biophys Res Commun 2010 0.80
37 Clinical, cellular and molecular phenotypes of aging bone. Interdiscip Top Gerontol 2010 0.79
38 New insights: elevated follicle-stimulating hormone and bone loss during the menopausal transition. Curr Rheumatol Rep 2009 0.79
39 Molecular cloning, expression, and function of osteoclastic calcineurin Aalpha. Am J Physiol Renal Physiol 2002 0.78
40 Evolution, aging, and osteoporosis. Ann N Y Acad Sci 2007 0.78
41 The effects of smoke carcinogens on bone. Curr Osteoporos Rep 2011 0.78
42 Paradigm shift in the pathophysiology of postmenopausal and thyrotoxic osteoporosis. Mt Sinai J Med 2009 0.78
43 New horizons in skeletal physiology and pathophysiology. Endocr Pract 2011 0.78
44 The crossover of bisphosphonates to cancer therapy. Ann N Y Acad Sci 2010 0.77
45 The skeletal subsystem as an integrative physiology paradigm. Curr Osteoporos Rep 2010 0.77
46 Role of the pituitary-bone axis in skeletal pathophysiology. Curr Opin Endocrinol Diabetes Obes 2009 0.76
47 From the gut to the strut: where inflammation reigns, bone abstains. J Clin Invest 2016 0.75
48 The pituitary-bone axis. Adv Exp Med Biol 2011 0.75
49 Molecules, mechanisms, and momentum in bone and cartilage research. Biochem Biophys Res Commun 2005 0.75